[product name]: Salvia miltiorrhiza extract

[English name]: Salvia Extract

[Active Ingredients]: Tanshinone IIA Tanshinone IIA

[alias]: Danshen 醌 II, Danshen 醌 IIA

[Plant source]: It is the dry root and rhizome of Salvia miltiorrhiza.

[product specifications]: 1%-98%

[Properties]: brown powder

[Test method]: HPLC

[CAS]: 568-72-9

[Molecular formula]: C19H18O3

[Molecular weight]: 294.34

[Physical properties]: Melting point 209 ° C ~ 210 ° C, soluble in ethanol, acetone, ether, benzene and other organic solvents, slightly soluble in water.

[Clinical application]: It is mainly used for the treatment of cardiovascular diseases. It has the functions of expanding blood vessels, reducing blood pressure and anti-thrombosis. It has significant curative effect on treating coronary heart disease, angina pectoris and arrhythmia.

[Use]: It can be used to prepare dripping pills, capsules, etc. It can be used clinically for coronary heart disease, angina pectoris, myocardial infarction, and also for premature ventricular contractions.

[Active Ingredients]: Danshensu Salvianic Acid

[product specifications]: 5%-98%

[Properties]: reddish brown powder.

[Test method]: HPLC

[Efficacy]:

(1) Treatment of coronary heart disease can improve coronary circulation and inhibit thrombosis.

(2) Effects on myocardial repair: Danshensu and tanshinone IIA can significantly prolong the time of hypoxia tolerance in mice, reduce myocardial damage caused by hypoxia, and improve myocardial contractility and promote myocardial regeneration.

(3) Effect on microcirculation: Danshen Shuxin Capsule can expand animal arterioles, increase the number of open capillaries, accelerate blood flow rate and flow, and thus improve microcirculation disturbance.

(4) Effects on blood rheology: Danshensu and tanshinone IIA inhibit ADP-induced platelet aggregation, inhibit platelet TXA2 synthesis and release vasoconstrictor and promote fibrin degradation. It can reduce the whole blood and plasma viscosity of patients with coronary heart disease, cerebral ischemic stroke and myocardial infarction, reduce hematocrit, and restore the patient's hemorheology index by anticoagulation and viscosity reduction.

(5) Effect on blood lipids: Danshensu can inhibit the synthesis of endogenous cholesterol, reduce the production of oxidized low-density lipoprotein (LDL), reduce neutral fat, and can be used for atherosclerosis caused by hyperlipidemia.

(6) Anti-infection, for purulent and surgical infections (acute tonsillitis, otitis externa, osteomyelitis, surgical infection, etc.).

(7) for the treatment of cervical erosion.

(8) Activating blood circulation, relieving qi and relieving pain.

[Storage]: Store in a cool, dry place, away from strong light, and away from high temperatures.

[Product packaging]: 1KG / sterilized aluminum foil bag; 25KG / cardboard drum; can be packaged according to customer requirements.

[Shelf life]: 24 months